☆ 4.7 Article

Platelets and SARS-CoV-2 During COVID-19: Immunity, Thrombosis, and Beyond

CIRCULATION RESEARCH (2023)

Related references

Note: Only part of the references are listed.

Article Immunology

A C57BL/6 Mouse Model of SARS-CoV-2 Infection Recapitulates Age- and Sex-Based Differences in Human COVID-19 Disease and Recovery

Michael A. Davis et al.

Summary: We conducted a comprehensive analysis of SARS-CoV-2 infection and recovery in mice and found that it closely resembles the acute human disease. Disease severity and infection kinetics were influenced by age and sex, with older mice and males exhibiting higher mortality rates and slower viral clearance. The pathological features observed in mice, including virus positivity in bronchial epithelial cells and lung damage, parallel those seen in humans. Our findings suggest that C57BL/6 mice can serve as a useful model for studying SARS-CoV-2 and other emerging coronaviruses.

VACCINES (2023)

Add to Collection

Article Immunology

Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae

Zoe Swank et al.

Summary: This study analyzed plasma samples from PASC and COVID-19 patients and found that spike protein of SARS-CoV-2 can be detected predominantly in PASC patients for up to 12 months.

CLINICAL INFECTIOUS DISEASES (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Human Cardiac Pericytes Are Susceptible to SARS-CoV-2 Infection

Brittany D. Brumback et al.

Summary: COVID-19 is associated with serious cardiovascular complications, and this study demonstrates that human cardiac pericytes are susceptible to SARS-CoV-2 infection. Viral entry into pericytes is mediated by endosomal proteases, leading to up-regulation of inflammatory markers and cell death. Evidence of cardiac pericyte infection was also found in COVID-19 myocarditis patients, suggesting a potential role for pericyte infection in COVID-19.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 Infection

Roberto Carnevale et al.

Summary: This study identified two pathways, TLR4-dependent and independent, that promote platelet-dependent thrombus growth. It suggests that inhibiting TLR4 or p47phox could be a strategy to counteract thrombosis in SARS-CoV-2.

CIRCULATION RESEARCH (2023)

Add to Collection

Review Cardiac & Cardiovascular Systems

Platelet and Megakaryocyte Roles in Innate and Adaptive Immunity

Milka Koupenova et al.

Summary: Platelets not only play important roles in hemostasis and thrombosis, but also have significant immune cell functions. Platelets interact and activate immune cells in response to pathogen exposures, infection, and tissue injury. The immune potential of platelets depends on their molecular composition provided by their megakaryocyte precursor, making them first responders in coordinating pathogen immune responses.

CIRCULATION RESEARCH (2022)

Add to Collection

Article Hematology

Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19

Norma Maugeri et al.

Summary: The study found that COVID-19 patients have activated platelets at admission, characterized by expression and distribution of HMGB1 and von Willebrand factor, accumulation of platelet-derived extracellular vesicles and HMGB1(+) plt-EVs in plasma. Platelets interacting with SARS-CoV-2 in vitro underwent activation, suggesting a potential role of platelet activation in the inflammatory and hemostatic manifestations of COVID-19.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection

Article Biotechnology & Applied Microbiology

A humanized mouse model of chronic COVID-19

Esen Sefik et al.

Summary: This study introduces a humanized mouse model of COVID-19 that replicates the immune response and pathological features of the infection, providing a valuable tool for investigating disease mechanisms and treatment options.

NATURE BIOTECHNOLOGY (2022)

Add to Collection

Article Immunology

Persistence of SARS CoV-2 S1 Protein in CD16+Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection

Bruce K. Patterson et al.

Summary: The recent study found that patients with post-acute sequelae of COVID-19 (PASC) had significantly elevated levels of intermediate and non-classical monocytes, and these cells contained SARS-CoV-2 S1 protein up to 15 months after infection. However, fragmented SARS-CoV-2 RNA was found in PASC patients with no full-length sequences identified. This suggests that non-classical monocytes may play a role in the inflammation seen in PASC.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation

Caroline Junqueira et al.

Summary: This study suggests that SARS-CoV-2 infection in monocytes and macrophages, mediated by antibody uptake, triggers inflammatory cell death and systemic inflammation, which prevents the production of infectious virus but contributes to COVID-19 pathogenesis.

NATURE (2022)

Add to Collection

Article Hematology

Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells

Florian Puhm et al.

Summary: Platelets are hyperactivated in COVID-19, but the mechanisms behind platelet activation by SARS-CoV-2 are not well understood. This study found that tissue factor (TF) produced by infected cells can activate platelets. Virions and extracellular vesicles (EVs) were also identified, and TF activity was associated with either the virus or the EVs. Blocking this pathway may interfere with platelet activation and the coagulation characteristics of COVID-19.

BLOOD ADVANCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19

Aiwei Zhu et al.

Summary: This study found that circulating platelets containing SARS-CoV-2 are closely associated with fatal outcomes in severe COVID-19 patients. The infected platelets may originate from bone marrow and lung megakaryocytes, which are also found infected in COVID-19 autopsies. The interaction between infected platelets and lung macrophages may have an impact on the pathogenesis of COVID-19.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Add to Collection

Article Cell Biology

Platelet proteome reveals features of cell death, antiviral response and viral replication in covid-19

Monique R. O. Trugilho et al.

Summary: Platelets play a significant role in the pathogenesis of COVID-19 through platelet activation, antiviral response, and disease severity.

CELL DEATH DISCOVERY (2022)

Add to Collection

Article Hematology

S100A8/A9 drives the formation of procoagulant platelets through GPIbα

Martina Colicchia et al.

Summary: S100A8/A9, secreted by activated myeloid cells, has antimicrobial, proinflammatory, and prothrombotic properties. Increased levels of S100A8/A9 in COVID-19 patients are associated with poor outcomes. S100A8/A9 is mainly detected in neutrophils and deposited on vessel walls in COVID-19 lungs. Platelets interact with S100A8/A9, leading to the formation of procoagulant platelets.

BLOOD (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales

Rochelle Knight et al.

Summary: Incidence of vascular diseases remains elevated up to 49 weeks after COVID-19 diagnosis, with a faster decline for arterial thromboses than VTEs. Patients hospitalized with COVID-19, non-White individuals, and those without previous events are at higher risk. Policies to prevent severe COVID-19, including vaccination, early post-discharge review, risk factor control, and secondary preventive agents, are supported by these findings.

CIRCULATION (2022)

Add to Collection

Article Virology

Comparison of Physical and Biochemical Characterizations of SARS-CoV-2 Inactivated by Different Treatments

Shouzhi Yu et al.

Summary: This study evaluated the effects of four different chemical inactivation methods on the physical and biochemical characteristics of SARS-CoV-2. Formaldehyde and beta-propiolactone treatment were found to completely inactivate the virus without significant effects on its morphology. However, formaldehyde treatment resulted in decreased viral S protein content, while long-term beta-propiolactone treatment led to increased viral particle aggregation. A 24-hour beta-propiolactone treatment was able to completely inactivate SARS-CoV-2 while preserving its morphology, physical properties, and biochemical properties.

VIRUSES-BASEL (2022)

Add to Collection

Article Multidisciplinary Sciences

Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia

Lucie Bernard-Raichon et al.

Summary: The authors demonstrate that SARS-CoV-2 infection causes dysbiosis in the gut microbiome and alterations in gut epithelial cells in a mouse model. They also correlate the observed dysbiosis in COVID-19 patients with bloodstream infections by matching bacterial sequences from stool samples to organisms found in the blood. This study provides evidence that dysbiosis in the gut microbiome is associated with translocation of bacteria into the blood during COVID-19, leading to life-threatening secondary infections.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Immunology

Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variants

Qi Li et al.

Summary: This study describes the development of VHH-IgA1.1, a nanobody IgA fusion molecule, as an affordable and less invasive inhalable treatment for SARS-CoV-2 Omicron variants. VHH-IgA1.1 shows potent neutralization activity against major global SARS-CoV-2 variants and provides effective mucosal immunity against Omicron infection. Intranasal administration of VHH-IgA1.1 offers significant protection from severe respiratory disease in mice infected with SARS-CoV-2 variants. Moreover, VHH-IgA1.1 produced in Pichia pastoris is cost-effective and comparable in potency to mammalian-produced antibodies.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Understanding COVID-19-associated coagulopathy

Edward M. Conway et al.

Summary: In this article, the authors discuss the emerging understanding of COVID-19-associated coagulopathy and the need to comprehend its cellular and molecular mechanisms. They categorize the current understanding into three main pathological mechanisms and address key questions and research gaps in order to improve diagnosis and treatment. The suitability of animal models for studying this condition is also considered.

NATURE REVIEWS IMMUNOLOGY (2022)

Add to Collection

Correction Cell Biology

Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2 (vol 32, pg 24, 2022)

Yunqing Gu et al.

CELL RESEARCH (2022)

Add to Collection

Article Medicine, Research & Experimental

Platelets mediate inflammatory monocyte activation by SARS-CoV-2 spike protein

Tianyang Li et al.

Summary: Infection with SARS-CoV-2 can lead to COVID-19, which ranges from mild to moderate disease but carries the risk of morbidity and mortality. Severe cases of COVID-19 are associated with hemostasis disorders, monocyte activation, and a cytokine storm, but the connection between these manifestations is not fully understood. This study reveals that the spike protein of SARS-CoV-2 interacts with P-selectin/PGSL-1 and CD40L/CD40, leading to proinflammatory cytokine production by monocytes. These findings provide an explanation for the correlation between hypercoagulation, monocyte activation, and a cytokine storm in severely affected COVID-19 patients, and suggest a potential target for therapeutic intervention.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Add to Collection

Article Immunology

Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes

Aline H. de Nooijer et al.

Summary: In COVID-19 patients, activation of the complement system is associated with disease severity, mortality rate, and thromboembolic events. This suggests components of the complement system could serve as potential prognostic markers and therapeutic targets in COVID-19.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Hematology

Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation

Soracha E. Ward et al.

Summary: EC activation plays a key role in the pathogenesis of severe COVID-19, as evidenced by increased plasma VWF:Ag and FVIII levels in patients. Elevated levels of VWF-FVIII complex and VWFpp were sustained for up to 3 weeks, with a reduced VWFpp/VWF:Ag ratio indicating decreased VWF clearance. Importantly, plasma VWFpp levels correlated with clinical severity indices in severe COVID-19, suggesting a potential role as a biomarker in this setting.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

COVID-19-neutralizing antibodies predict disease severity and survival

Wilfredo F. Garcia-Beltran et al.

Summary: Severe cases of COVID-19 show increased inflammatory markers, lymphopenia, pro-inflammatory cytokines, and high antibody levels. High neutralization potency is a predictor of survival. Patient sera can neutralize different strains, indicating cross-protection from reinfection.

CELL (2021)

Add to Collection

Article Cell Biology

AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells

Shuai Wang et al.

Summary: This study found that AXL may serve as a novel receptor for SARS-CoV-2, playing an important role in promoting viral infection of the human respiratory system. AXL expression level is closely correlated with SARS-CoV-2 S level and could be a potential target for future clinical intervention strategies.

CELL RESEARCH (2021)

Add to Collection

Article Medicine, Research & Experimental

Lung megakaryocytes are immune modulatory cells

Daphne N. Pariser et al.

Summary: Platelets, previously known as cellular mediators of thrombosis, are also immune cells that interact with immune cells, impacting their activation and differentiation. Lung megakaryocytes (Mk(L)) have gene expression patterns similar to antigen-presenting cells, and have key immune regulatory roles influenced by the tissue environment. This indicates the plasticity of the immune phenotype of Mk(L) and their ability to induce T cell activation.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Article Multidisciplinary Sciences

No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor

Jarrod Shilts et al.

Summary: Recent studies suggest that basigin may not be the receptor for SARS-CoV-2 virus to invade human cells, and removing basigin from the surface of human lung epithelial cells does not affect susceptibility to the virus. These findings provide more information for a better understanding and treatment of COVID-19.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Cell Biology

MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells

Xin Yin et al.

Summary: Recent studies show that cellular responses to SARS-CoV-2 infection may influence disease severity, with MDA5 and LGP2 primarily regulating IFN induction in lung epithelial cells. Further analysis revealed that viral intermediates specifically activate the IFN response through MDA5-mediated sensing, and transcription factors IRF3, IRF5, and NF-kappa B/p65 play key roles in regulating the IFN response during SARS-CoV-2 infection. These findings provide valuable insights into the molecular mechanisms of innate immune recognition and signaling response to SARS-CoV-2.

CELL REPORTS (2021)

Add to Collection

Article Medicine, General & Internal

Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19 The ACTIV-4B Randomized Clinical Trial

Jean M. Connors et al.

Summary: This study aimed to assess the impact of anticoagulant or antiplatelet therapy on symptomatic clinically stable outpatients with COVID-19. The results showed that treatment with aspirin or apixaban compared with placebo did not reduce the rate of a composite clinical outcome, and the study was terminated early due to a lower than anticipated event rate.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Medicine, General & Internal

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

Anthony C. Gordon et al.

Summary: Interleukin-6 receptor antagonists tocilizumab and sarilumab were found to improve outcomes, including survival, in critically ill patients with Covid-19 receiving organ support in ICUs according to an ongoing international trial. The efficacy of these treatments has been confirmed, with patients benefiting from the therapy.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Virology

Inactivation of SARS-CoV-2 by β-propiolactone causes aggregation of viral particles and loss of antigenic potential

Divya Gupta et al.

Summary: The study found the inactivation effect of beta-propiolactone (BPL) on SARS-CoV-2 at different concentrations, with high concentrations leading to the loss of virion particles and potentially reducing antigenic potential. The research also indicated that viral RNA content can indirectly reflect the antigenic content of the virus.

VIRUS RESEARCH (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19-associated Coagulopathies

Ethan S. Fitzgerald et al.

Summary: The research investigated how SARS-CoV-2 infection impacts the molecular basis of blood coagulation, revealing that it induces the extrinsic blood coagulation cascade and suppresses the plasminogen activation system. This may lead to diverse coagulopathies in lung and distal organ systems.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination

Zhengrong Zhang et al.

Summary: In COVID-19 patients, SARS-CoV-2 infection leads to the presence of heterotypic cell-in-cell structures in lung tissues with lymphocytes inside multinucleate syncytia. The membrane fusion induced by the spike glycoprotein is controlled by a bi-arginine motif, and candidate anti-viral drugs can efficiently inhibit this process. This study provides insights into the molecular and cellular mechanisms of SARS-CoV-2 pathogenesis and identifies potential novel targets for COVID-19 therapy.

CELL DEATH AND DIFFERENTIATION (2021)

Add to Collection

Letter Cell Biology

SARS-CoV-2 spike protein interacts with and activates TLR41

Yingchi Zhao et al.

CELL RESEARCH (2021)

Add to Collection

Review Immunology

Circulating Calprotectin as a Biomarker of COVID-19 Severity

Michael Mahler et al.

Summary: Calprotectin is a promising serological biomarker for risk assessment of COVID-19 patients, especially in those with severe pulmonary disease.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia

Luca Braga et al.

Summary: COVID-19 patients' lungs contain infected pneumocytes with abnormal morphology and frequent multinucleation, leading to the formation of syncytia driven by the activation of the SARS-CoV-2 spike protein. The antihelminthic drug niclosamide has shown to effectively inhibit cell fusion, potentially providing a new therapeutic approach for COVID-19 disease pathogenesis.

NATURE (2021)

Add to Collection

Article Immunology

TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines

Min Zheng et al.

Summary: The study revealed that the envelope protein of SARS-CoV-2 is sensed by TLR2, leading to the production of inflammatory cytokines, and the severity of the disease is associated with the expression of TLR2 and MYD88. The findings demonstrate the critical role of TLR2 signaling in promoting proinflammatory cytokine production during coronavirus infection, providing new insights for therapeutic strategies against the ongoing COVID-19 pandemic.

NATURE IMMUNOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Effect of Crizanlizumab, a P-Selection inhibitor, in COVID-19 A Placebo-Controlled, Randomized Trial

Thorsten M. Leucker et al.

Summary: The P-selectin inhibitor, crizanlizumab, effectively reduced levels of P-selectin and may induce thrombolysis in COVID-19 patients. However, there were no significant differences in clinical endpoints between crizanlizumab and placebo, and crizanlizumab was well tolerated by patients.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)

Add to Collection

Article Immunology

A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection

Fiachra Humphries et al.

Summary: This study describes a compound, diABZI-4, that activates stimulator of interferon genes (STING) and effectively limits SARS-CoV-2 replication in cells and animals. The administration of diABZI-4 intranasally in mice provided complete protection from severe respiratory disease caused by SARS-CoV-2. It induces a rapid, short-lived activation of STING, leading to transient proinflammatory cytokine production and lymphocyte activation in the lung, ultimately inhibiting viral replication. The study supports the use of diABZI-4 as a host-directed therapy for the treatment and prevention of COVID-19.

SCIENCE IMMUNOLOGY (2021)

Add to Collection

Article Hematology

Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets

Alexander P. Bye et al.

Summary: Critically ill patients with COVID-19 may experience thrombosis due to excessive immune response, with immune complexes containing SARS-CoV-2 spike protein and anti-spike immunoglobulin G exacerbating platelet-mediated thrombosis in vitro when Fc domain glycosylation state is modified to mimic that in severe COVID-19 cases. Activation is dependent on Fc gamma RIIA, and small molecules such as R406, ibrutinib, and cangrelor may counteract pathogenic platelet activation.

BLOOD (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

SARS-CoV-2 Initiates Programmed Cell Death in Platelets

Milka Koupenova et al.

Summary: The study revealed that platelets in COVID-19 patients contain viral RNA and proteins, and that SARS-CoV-2 can directly influence platelet internalization and cell death, which may contribute to complications like thrombosis.

CIRCULATION RESEARCH (2021)

Add to Collection

Article Hematology

Platelets contribute to disease severity in COVID-19

Tessa J. Barrett et al.

Summary: Platelet count, size, and maturity are associated with increased critical illness and all-cause mortality among hospitalized COVID-19 patients. SARS-CoV-2 virions enter megakaryocytes and platelets in COVID-19 patients, leading to alterations in the platelet transcriptome and activation profile. In vitro mechanistic studies show that the interaction of SARS-CoV-2 with megakaryocytes causes distinct effects on platelets compared to the coronavirus responsible for the common cold (CoV-OC43).

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Article Medicine, General & Internal

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

Ewan C. Goligher et al.

Summary: In critically ill patients with Covid-19, initial therapeutic-dose anticoagulation did not result in improved survival rates or fewer days requiring cardiovascular or respiratory organ support compared to usual-care pharmacologic thromboprophylaxis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Cell Biology

Thrombosis in Covid-19 and non-Covid-19 pneumonia: role of platelets

Francesco Violi et al.

Summary: This review compares the type of vascular diseases complicating CAP and Covid-19, evaluates the different roles of platelets in both diseases, and discusses the potential usefulness of antiplatelet treatment in improving clinical outcomes. Until now, antiplatelet treatment has not been widely considered for Covid-19, but interventional trials are ongoing to explore this issue.

PLATELETS (2021)

Add to Collection

Article Multidisciplinary Sciences

The C5a/C5a receptor 1 axis controls tissue neovascularization through CXCL4 release from platelets

Henry Nording et al.

Summary: This study reveals that platelets negatively modulate revascularization through C5aR1 activation, inhibiting endothelial cell functions. By identifying the C5a/C5aR1-CXCL4 axis in platelets, a mechanism for controlling tissue neovascularization has been uncovered.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Gastroenterology & Hepatology

Low-Grade Endotoxemia and Thrombosis in COVID-19

Alessandra Oliva et al.

Summary: This study found that low-grade endotoxemia is detectable in patients with COVID-19 and is associated with thrombotic events. LPS and D-dimer can independently predict thrombotic events in COVID-19 patients.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2021)

Add to Collection

Article Chemistry, Multidisciplinary

CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2

Razie Amraei et al.

Summary: The study identified CD209L and CD209 as receptors for SARS-CoV-2 entry into human cells. CD209L is prominently expressed in lung and kidney tissues and interacts with ACE2, potentially playing a role in SARS-CoV-2 infection. This finding may have implications for antiviral drug development in tissues where ACE2 expression is low or absent.

ACS CENTRAL SCIENCE (2021)

Add to Collection

Article Microbiology

Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein

Robert J. Ragotte et al.

Summary: This study confirms that the receptor binding domain (RBD) of the SARS-CoV-2 spike glycoprotein cannot form a complex with basigin, casting doubt on its role as a viral coreceptor and potential therapeutic target.

MSPHERE (2021)

Add to Collection

Article Multidisciplinary Sciences

Platelets amplify endotheliopathy in COVID-19

Tessa J. Barrett et al.

Summary: The study reveals an inflammatory hypercoagulable state between platelets and endothelial cells in COVID-19, with platelet-released factors promoting endotheliopathy. S100A8, S100A9, and their protein product MRP8/14 are enriched in COVID-19 platelets and contribute significantly to poor clinical outcomes. Targeting platelet P2Y(12) appears to be a promising strategy for reducing proinflammatory platelet-endothelial interactions in COVID-19.

SCIENCE ADVANCES (2021)

Add to Collection

Article Medicine, Research & Experimental

Highly susceptible SARS-CoV-2 model in CAG promoter-driven hACE2-transgenic mice

Masamitsu N. Asaka et al.

Summary: A highly susceptible animal model of SARS-CoV-2 infection was established in CAG-hACE2 mice via intratracheal tract infection. The mice exhibited severe symptoms of infection, making them suitable for evaluating vaccines and therapeutic medicines.

JCI INSIGHT (2021)

Add to Collection

Article Medicine, Research & Experimental

SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7/8

Valentina Salvi et al.

Summary: The inflammatory and IFN pathways of innate immunity are crucial in the resistance and pathogenesis of COVID-19. Single-stranded RNA fragments from the SARS-CoV-2 genome were identified as direct activators of endosomal TLR7/8 and MyD88 pathway, inducing human DC activation and inflammatory responses. The virus endosomal processing products can potentiate IFN and inflammatory responses, playing a key role in host resistance and COVID-19 pathogenesis.

JCI INSIGHT (2021)

Add to Collection

Article Hematology

Risk of thrombotic complications in influenza versus COVID-19 hospitalized patients

Milou A. M. Stals et al.

Summary: A comparison study was conducted on thrombotic complications in hospitalized patients with influenza and COVID-19, revealing a significantly higher incidence of thrombotic complications in COVID-19 patients, especially in those admitted to the Intensive Care Unit, mainly driven by venous thrombotic complications.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Article Multidisciplinary Sciences

COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice

Jian Zheng et al.

Summary: The COVID-19 pandemic is associated with significant morbidity and mortality. Experimental studies in animals infected with SARS-CoV-2 have revealed severe lung and brain damage, as well as early onset anosmia in mice. Excitingly, infusion of convalescent plasma from recovered patients has shown to protect against lethal disease, though it does not prevent anosmia.

NATURE (2021)

Add to Collection

Article Hematology

Platelets Endocytose Viral Particles and Are Activated via TLR (Toll-Like Receptor) Signaling

Meenakshi Banerjee et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann et al.

CELL (2020)

Add to Collection

Article Immunology

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China

Chuan Qin et al.

CLINICAL INFECTIOUS DISEASES (2020)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 productively infects human gut enterocytes

Mart M. Lamers et al.

SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model

Barry Rockx et al.

SCIENCE (2020)

Add to Collection

Editorial Material Multidisciplinary Sciences

Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients

Yonggang Zhou et al.

NATIONAL SCIENCE REVIEW (2020)

Add to Collection

Article Medicine, General & Internal

Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients

Jin Liu et al.

EBIOMEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

Linlin Bao et al.

NATURE (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy

Leo Nicolai et al.

CIRCULATION (2020)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Platelet and Vascular Biomarkers Associate With Thrombosis and Death in Coronavirus Disease

Tessa J. Barrett et al.

CIRCULATION RESEARCH (2020)

Add to Collection

Article Medical Laboratory Technology

Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

Giuseppe Lippi et al.

CLINICA CHIMICA ACTA (2020)

Add to Collection

Review Immunology

COVID-19 pathophysiology: A review

Koichi Yuki et al.

CLINICAL IMMUNOLOGY (2020)

Add to Collection

Article Hematology

Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome

Elizabeth A. Middleton et al.

BLOOD (2020)

Add to Collection

Article Hematology

Platelet gene expression and function in patients with COVID-19

Bhanu Kanth Manne et al.

BLOOD (2020)

Add to Collection

Review Immunology

Fc Gamma Receptors and Their Role in Antigen Uptake, Presentation, and T Cell Activation

Fabian Junker et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Hematology

Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study

George Goshua et al.

LANCET HAEMATOLOGY (2020)

Add to Collection

Article Immunology

Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling

Benjamin Israelow et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Add to Collection

Article Hematology

Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19

Eugenio D. Hottz et al.

BLOOD (2020)

Add to Collection

Article Biochemistry & Molecular Biology

A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice

Sarah R. Leist et al.

CELL (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Platelets Can Associate With SARS-CoV-2 RNA and Are Hyperactivated in COVID-19

Younes Zaid et al.

CIRCULATION RESEARCH (2020)

Add to Collection

Article Multidisciplinary Sciences

Clinical characteristics of 82 cases of death from COVID-19

Bicheng Zhang et al.

PLOS ONE (2020)

Add to Collection

Article Medicine, General & Internal

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis

Jonathan A. C. Sterne et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Medicine, Research & Experimental

Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis

Panagiotis Skendros et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection

Article Hematology

COVID-19 patients exhibit reduced procoagulant platelet responses

Frederik Denorme et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Hematology

Yersinia pestisescapes entrapment in thrombi by targeting platelet function

Samantha G. Palace et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Immunology

SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function

Emma S. Winkler et al.

NATURE IMMUNOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production

Yuezhou Chen et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells

Ke Wang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Add to Collection

Article Immunology

Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy

Dimitrios C. Mastellos et al.

CLINICAL IMMUNOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology

Rossana Bussani et al.

EBIOMEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 viral load is associated with increased disease severity and mortality

Jesse Fajnzylber et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Hematology

Potential role of platelets in COVID-19: Implications for thrombosis

Milka Koupenova

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Multidisciplinary Sciences

The role of platelets in mediating a response to human influenza infection

Milka Koupenova et al.

NATURE COMMUNICATIONS (2019)

Add to Collection

Article Hematology

TNF-α driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging

Pavel Davizon-Castillo et al.

BLOOD (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis

Reinhard J. Sauter et al.

CIRCULATION (2018)

Add to Collection

Review Cardiac & Cardiovascular Systems

Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis

Milka Koupenova et al.

CIRCULATION RESEARCH (2018)

Add to Collection

Article Immunology

Platelets Enhance Dendritic Cell Responses against Staphylococcus aureus through CD40-CD40L

Sharmeen Nishat et al.

INFECTION AND IMMUNITY (2018)

Add to Collection

Review Pharmacology & Pharmacy

Biology of Platelet Purinergic Receptors and Implications for Platelet Heterogeneity

Milka Koupenova et al.

FRONTIERS IN PHARMACOLOGY (2018)

Add to Collection

Review Immunology

S100 Proteins As an Important Regulator of Macrophage Inflammation

Chang Xia et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Article Multidisciplinary Sciences

Dynamic modulation of DC-SIGN and FcYR2A receptors expression on platelets in dengue

Sojit Tomo et al.

PLOS ONE (2018)

Add to Collection

Article Medicine, Research & Experimental

Neutrophil accumulation and NET release contribute to thrombosis in HIT

Kandace Gollomp et al.

JCI INSIGHT (2018)

Add to Collection

Review Cardiac & Cardiovascular Systems

Thrombosis and platelets: an update

Milka Koupenova et al.

EUROPEAN HEART JOURNAL (2017)

Add to Collection

Article Immunology

MLKL, the Protein that Mediates Necroptosis, Also Regulates Endosomal Trafficking and Extracellular Vesicle Generation

Seongmin Yoon et al.

IMMUNITY (2017)

Add to Collection

Article Clinical Neurology

Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation

Rong Jin et al.

STROKE (2017)

Add to Collection

Article Hematology

The role of RNA uptake in platelet heterogeneity

Lauren Clancy et al.

THROMBOSIS AND HAEMOSTASIS (2017)

Add to Collection

Review Immunology

Programmed Cell Death and Inflammation: Winter Is Coming

Joseph P. Kolb et al.

TRENDS IN IMMUNOLOGY (2017)

Add to Collection

Article Hematology

A novel humanized mouse model with significant improvement of class-switched, antigen-specific antibody production

Hua Yu et al.

BLOOD (2017)

Add to Collection

Article Multidisciplinary Sciences

Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity

Janette Bester et al.

SCIENTIFIC REPORTS (2016)

Add to Collection

Article Rheumatology

Platelet-Derived S100A8/A9 and Cardiovascular Disease in Systemic Lupus Erythematosus

Christian Lood et al.

ARTHRITIS & RHEUMATOLOGY (2016)

Add to Collection

Article Hematology

Sex Differences in Platelet Toll-Like Receptors and Their Association With Cardiovascular Risk Factors

Milka Koupenova et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)

Add to Collection

Review Immunology

The platelet Fc receptor, FcγRIIa

Jianlin Qiao et al.

IMMUNOLOGICAL REVIEWS (2015)

Add to Collection

Article Multidisciplinary Sciences

Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature

Elzbieta Kolaczkowska et al.

NATURE COMMUNICATIONS (2015)

Add to Collection

Review Immunology

DAMPs from cell death to new life

Emilie Venereau et al.

FRONTIERS IN IMMUNOLOGY (2015)

Add to Collection

Article Hematology

Influenza virus H1N1 activates platelets through FcγRIIA signaling and thrombin generation

Eric Boilard et al.

BLOOD (2014)

Add to Collection

Article Hematology

Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis

Milka Koupenova et al.

BLOOD (2014)

Add to Collection

Article Medicine, Research & Experimental

Platelet-derived S100 family member myeloidrelated protein-14 regulates thrombosis

Yunmei Wang et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Add to Collection

Article Hematology

Platelets provoke distinct dynamics of immune responses by differentially regulating CD4+ T-cell proliferation

L. Zhu et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)

Add to Collection

Article Biotechnology & Applied Microbiology

Development and function of human innate immune cells in a humanized mouse model

Anthony Rongvaux et al.

NATURE BIOTECHNOLOGY (2014)

Add to Collection

Article Hematology

Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation

Eugenio D. Hottz et al.

BLOOD (2013)

Add to Collection

Review Cell Biology

The incredible journey: From megakaryocyte development to platelet formation

Kellie R. Machlus et al.

JOURNAL OF CELL BIOLOGY (2013)

Add to Collection

Article Immunology

Lipopolysaccharide Stimulates Platelets through an IL-1β Autocrine Loop

G. Thomas Brown et al.

JOURNAL OF IMMUNOLOGY (2013)

Add to Collection

Article Hematology

Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases

E. D. Hottz et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)

Add to Collection

Article Hematology

Sepsis and Thrombosis

Marcel Levi et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2013)

Add to Collection

Article Hematology

Platelet adhesion to collagen

Benedicte P. Nuyttens et al.

THROMBOSIS RESEARCH (2011)

Add to Collection

Review Immunology

Platelets and the immune continuum

John W. Semple et al.

NATURE REVIEWS IMMUNOLOGY (2011)

Add to Collection

Article Hematology

Expression of EMMPRIN (CD147) on circulating platelets in vivo

G. J. Pennings et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)

Add to Collection

Review Hematology

Platelet α-granules: Basic biology and clinical correlates

Price Blair et al.

BLOOD REVIEWS (2009)

Add to Collection

Article Cardiac & Cardiovascular Systems

Stimulation of Toll-Like Receptor 2 in Human Platelets Induces a Thromboinflammatory Response Through Activation of Phosphoinositide 3-Kinase

Price Blair et al.

CIRCULATION RESEARCH (2009)

Add to Collection

Review Medicine, General & Internal

Mechanisms of disease: Mechanisms of thrombus formation

Bruce Furie et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Add to Collection

Article Hematology

Proteomic analysis of platelet α-granules using mass spectrometry

D. M. Maynard et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)

Add to Collection

Article Biochemistry & Molecular Biology

Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood

Stephen R. Clark et al.

NATURE MEDICINE (2007)

Add to Collection

Article Virology

Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus

Paul B. McCray et al.

JOURNAL OF VIROLOGY (2007)

Add to Collection

Article Virology

DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets

Chawaree Chaipan et al.

JOURNAL OF VIROLOGY (2006)

Add to Collection

Article Immunology

Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression

M Nishimura et al.

JOURNAL OF IMMUNOLOGY (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.